Here are what the editors at HealthDay consider to be the most important developments in Urology for February 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Male Pattern Baldness Linked to Prostate Symptoms
FRIDAY, Feb. 24 (HealthDay News) -- Early-onset of male pattern baldness (androgenetic alopecia [AGA]) may be a marker of male urinary symptoms associated with an enlarged prostate, according to a study published in the March issue of the Journal of the American Academy of Dermatology.
Alcohol Dependence Significant Problem for U.S. Surgeons
TUESDAY, Feb. 21 (HealthDay News) -- A considerable number of U.S. surgeons have alcohol abuse and dependence, which is more likely in those who have recently reported major errors, are burned out, and are depressed, according to a study published in the February issue of the Archives of Surgery.
2002 to 2008 Saw Increase in Partial Nephrectomy Use
FRIDAY, Feb. 17 (HealthDay News) -- In the United States, the use of partial nephrectomy procedures to manage renal masses in patients with renal cell carcinoma (RCC) increased significantly from 2002 to 2008, according to research published in the March issue of The Journal of Urology.
Open-Angle Glaucoma Linked to Erectile Dysfunction
FRIDAY, Feb. 17 (HealthDay News) -- Men with erectile dysfunction (ED) are almost three times more likely to have been previously diagnosed with glaucoma, according to a study published in the February issue of Ophthalmology.
Chickens Harbor E. coli Found in Human UTIs
THURSDAY, Feb. 16 (HealthDay News) -- Retail purchased chicken may be the source of extraintestinal pathogenic Escherichia coli (ExPEC) that causes urinary tract infections (UTIs) in humans, according to a study published online Feb. 15 in Emerging Infectious Diseases.
Female Sexual Function Improves After Lesion Surgery
THURSDAY, Feb. 16 (HealthDay News) -- Women with deep infiltrating endometriosis (DIE) who undergo laparoscopic excision and postoperative combined oral contraceptive (COC) therapy have improved postoperative sexual function, according to a study published online Feb. 9 in The Journal of Sexual Medicine.
Age, Nerve Sparing Tied to Post-Prostatectomy Sexual Function
THURSDAY, Feb. 16 (HealthDay News) -- Younger men and those who undergo bilateral nerve sparing (BNS) approaches during a robotic-assisted laparoscopic radical prostatectomy (RALP) have better recovery of their premorbid orgasmic function compared to older men or men with unilateral or non-nerve sparing surgery, according to a study published in the February issue of the BJU International.
Urinary Tract Infections More Common in Obese
TUESDAY, Feb. 14 (HealthDay News) -- Obese individuals are more likely to be diagnosed with a urinary tract infection (UTI) or pyelonephritis compared with nonobese individuals, according to a study published in the February issue of Urology.
Coronary Artery Disease Linked to Risk of Prostate Cancer
MONDAY, Feb. 13 (HealthDay News) -- A significant correlation between coronary artery disease (CAD) and prostate cancer (PCa) has been found among men participating in a prostate drug trial, according to research published online Feb. 7 in Cancer Epidemiology, Biomarkers & Prevention.
Robotic Surgery Repairs Urinary Tract Obstruction
FRIDAY, Feb. 10 (HealthDay News) -- Robot-assisted laparoscopic pyeloplasty (RLP) is safe and efficacious for the repair of ureteropelvic junction obstruction (UPJO), according to a study published in the February issue of Urology.
Cefpodoxime Not Recommended for Acute, Uncomplicated Cystitis
TUESDAY, Feb. 7 (HealthDay News) -- Cefpodoxime should not be used as a first-line fluoroquinolone-sparing antimicrobial for acute uncomplicated cystitis, according to a study published in the Feb. 8 issue of the Journal of the American Medical Association.
Prostate Size Predicts Gleason Score Upgrading
FRIDAY, Feb. 3 (HealthDay News) -- For men with low-risk prostate cancer, prostate size is an independent predictor of Gleason score upgrading, according to a study published in the December issue of The Journal of Urology.
Therapeutic Ultrasound May Be Potential Male Contraceptive
THURSDAY, Feb. 2 (HealthDay News) -- A commercially available therapeutic ultrasound generator and transducer can reduce sperm counts in male rats to levels which would result in infertility in humans, according to a study published online Jan. 30 in Reproductive Biology and Endocrinology.
Copyright © 2012 ScoutNews, LLC. All rights reserved.
|Previous: February 2012 Briefing - Surgery||Next: February 2012 Briefing - Internal Medicine|
Reader comments on this article are listed below. Review our comments policy.